National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant interferon alpha-2a
A non-glycosylated recombinant human alpha interferon, subtype 2a, produced in the bacterium E. coli. Interferon alpha-2a binds to its specific cell-surface receptor, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune modulating effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Alpha 2 Interferon
IFN alpha-2A
IFN-Alpha 2
Interferon Alfa
Interferon alfa 2a
Recombinant Interferon Alfa-2a
US brand names:Alferon
Roferon-A
Foreign brand names:Laroferon
Roceron
Roceron-A
Abbreviation:rHuIFN-a 2a



Previous:recombinant human stem cell factor, recombinant interferon, recombinant interferon alfa, recombinant interferon alfa-2b, recombinant interferon alpha-1b
Next:recombinant interferon beta, recombinant interferon gamma, recombinant interleukin-1-alpha, recombinant interleukin-1-beta, recombinant interleukin-11

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov